aTYR PHARMA (ATYR) Preferred Dividend Payments (2014 - 2015)
aTYR PHARMA's (ATYR) quarterly Preferred Dividend Payments came in at $15000.0 in Q2 2015, down 89.21% on a YoY basis from $139000.0 in Q2 2014, and down 89.21% quarter-over-quarter from $139000.0 in Q3 2014.
Powered by 
Analysis
aTYR PHARMA (ATYR) Preferred Dividend Payments (2014 - 2015) Analysis & Trends
aTYR PHARMA (ATYR) has reported Preferred Dividend Payments for 2 consecutive years, with $15000.0 the latest figure, recorded in Q2 2015.
- For the quarter ending Q2 2015, Preferred Dividend Payments fell 89.21% year-over-year to $15000.0; the trailing twelve-month figure through Dec 2015 stood at $15000.0 (down 96.39% YoY), and the FY2015 full-year result was $15000.0, down 96.39% from the prior year.
- Preferred Dividend Payments fell to $15000.0 in Q2 2015 per ATYR's latest filing, from $139000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $139000.0 in Q2 2014 and bottomed at $15000.0 in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | - |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | aTYR PHARMA | 35.31 Mn | -22.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 15,000.00 |
| Sep 30, 2014 | 139,000.00 |
| Jun 30, 2014 | 139,000.00 |
| Mar 31, 2014 | 138,000.00 |